Pro Dex Inc (PDEX) stock
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/3010% below fair value
$63.94+2.01 (+3.25%)
Close on Nov 18, 2026Market cap $204.61MP/E 17.6Yield –
Pro Dex free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Pro Dex's free cash flow for the twelve months ending Sep 30, 2026 was $10.69M. For fiscal 2026 it was $6.76M. The highest annual figure on record is $6.76M in fiscal 2026.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $6.76M | – |
| FY2025 | Jun 30, 2025 | -$2.93M | – |
| FY2022 | Jun 30, 2022 | -$2.49M | – |
| FY2021 | Jun 30, 2021 | -$3.85M | -186.9% |
| FY2020 | Jun 30, 2020 | $4.43M | +128.3% |
| FY2019 | Jun 30, 2019 | $1.94M | -10.8% |
| FY2018 | Jun 30, 2018 | $2.17M | -17.3% |
| FY2017 | Jun 30, 2017 | $2.63M | +1596.1% |
| FY2016 | Jun 30, 2016 | $155.00K | – |
| FY2015 | Jun 30, 2015 | -$1.02M | – |
| FY2014 | Jun 30, 2014 | -$379.00K | – |
| FY2013 | Jun 30, 2013 | -$1.36M | – |
| FY2012 | Jun 30, 2012 | -$296.00K | -111.2% |
| FY2011 | Jun 30, 2011 | $2.63M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $6.14M | +177.8% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$476.00K | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $1.52M | +165.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $3.50M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $2.21M | +51.9% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$266.00K | -106.7% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $574.00K | +645.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$4.69M | -1863.9% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $1.46M | -33.9% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $3.96M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $77.00K | -97.2% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $266.00K | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $2.20M | +14586.7% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$904.00K | -169.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $2.71M | +46.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$5.65M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $15.00K | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $1.29M | -25.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $1.85M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$172.00K | -106.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$4.44M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $1.75M | +25.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$977.00K | -215.3% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.55M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$365.00K | -134.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $1.39M | +72.3% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $847.00K | +432.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$98.00K | -108.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.07M | +182.1% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $809.00K | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $159.00K | -82.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $1.20M | -4.5% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $379.00K | -61.5% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$332.00K | -174.6% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $922.00K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $1.26M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $984.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $445.00K | – |
See a number that looks wrong?